IWK

1.902.470.8888

1.888.470.5888

Emergency: 911
Telecare: 811
Poison: 1-800-565-8161
5850/5980 University Ave., Halifax, NS B3K 6R8

Children with BPD/CLD : Palivizumab (Synagis®)

updated: November 2017

Seasonal administration of palivizumab should be considered for children <24 months of age with bronchopulmonary dysplasia (BPD) / chronic lung disease (CLD) and who have required oxygen within 6 months preceding the RSV season(i.e. June 1st - November 2017), or other pulmonary disorders requiring oxygen therapy (e.g. hypoplastic lung).